ALK (4A4), mAb, Mouse
Anaplastic lymphoma kinase (ALK) known as ALK tyrosine kinase receptor or CD246, is a tyrosine kinase receptor. ALK is an important biomarker for diagnosis of non-small cell lung cancer (NSCLC). Zykadia (Ceritinib) has been permitted for treating patent with ALK-Positive NSCLC.
V02101 | |
|
|
詢價 | |
|
|
|
|
聯(lián)系我們 |